Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis

Author: Chervinsky Paul   Nayak Anjuli   Rooklin Anthony   Danzig Melvyn  

Publisher: OceanSide Publications, Inc

ISSN: 1539-6304

Source: Allergy and Asthma Proceedings, Vol.26, Iss.5, 2005-09, pp. : 391-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content